United Kingdom· GB-APID-33655311000001102
Exemestane 25mg tablets
A exemestane product containing exemestane, registered in United Kingdom by Morningside Healthcare Ltd. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Exemestane is registered in 17 of 19 countries.
Countries holding a registration under ATC L02BG06 (exemestane), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Exemestane · ATC L02BG06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of exemestane costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $1.43 in France to $3.32 in Switzerland — a ×2.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Exemestane · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.32
- IT Italy$2.46
- FR France$1.43
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Exemestane
- Manufacturer
- Morningside Healthcare Ltd
- Country
- United Kingdom (GB)
- ATC code
- L02BG06
- ATC class
- Exemestane
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5055132712241
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
236 interactions on record for exemestane.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Exemestane · interactions on record
236 records
- 1 severe
- 83 moderate
- 152 info
Most severe, free to view
- ThalidomideL04AX02severe
- TroglitazoneA10BG01moderate
- SulfinpyrazonB01AC12moderate
- FostamatinibB02BX09moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Exemestane in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAromasinPharmacia & Upjohn Company LLC
- CanadaACT EXEMESTANETEVA CANADA LIMITED
- IcelandAromasinPfizer ApS
- CzechiaAROMASINPfizer, spol. s r.o., Praha
- ItalyAROMASINMEDIFARM S.R.L.
- SpainAROMASIL 25 mg COMPRIMIDOS RECUBIERTOSPfizer S.L.
- FranceAROMASINE 25 mg, comprimé enrobéPFIZER HOLDING FRANCE
- GermanyAromasinPfizer Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aromasin, Exemestan Accord
- Belgium · Aromasin, Exemestan Sandoz
- Bulgaria · Аромазин, Екземегратис
- Cyprus · Exedral
- Czechia · Aromasin, Astexana
- Germany · Aromasin, Exemestan 1 A Pharma
- Denmark · Aromasin, Exemestan Accord
- Estonia · Aromasin, Exemestane Accord
- Spain · Aromasil, Exemestano Aurovitas
- Finland · Aromasin, Exemestan Pfizer
- France · Aromasine, Exemestane Accord
- Greece · Aromaplex, Aromasin
- Croatia · Aromasin, Eksemestan Jgl
- Hungary · Aromasin, Exemestane Pharmacenter
- Ireland · Aromasin, Exemestane Accord
- Iceland · Aromasin, Exemestan Actavis
- Italy · Aromasin, Axelta
- Lithuania · Aromasin, Exemestane Accord
- Luxembourg · Aromasin, Exemestan Ratiopharm
- Latvia · Exemestane Accord, Exemestane Sanoswiss
- Malta · Aromasin, Exedral 25
- Netherlands · Aromasin, Exemestaan Accord
- Norway · Aromasin, Exemestan Sandoz
- Poland · Astexana, Glandex
- Portugal · Aromasin, Exemestano Accord
- Romania · Aromasin, Exemestan Accord
- Sweden · Exemestan Actavis, Exemestan Sandoz
- Slovenia · Aromasin
- Slovakia · Aromasin, Astexana
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ccef9dbc-09fc-4983-b528-549fcadd2f89 GET /v1/drugs/ccef9dbc-09fc-4983-b528-549fcadd2f89?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "33655311000001102",
"desc": "Exemestane 25mg tablets (Morningside Healthcare Ltd)",
"form": "Oral tablet",
"vpid": "42294511000001105",
"source": "dmd",
"vtm_id": "775912004",
"strength": "25 mg",
"substance": "Exemestane",
"ingredient": "Exemestane",
"supplier_code": "10246711000001109"
}See everything about exemestane.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.